Literature DB >> 20116689

Secondary hyperparathyroidism and anemia in children treated by hemodialysis.

Lorie B Smith1, Jeffrey J Fadrowski, Chanelle J Howe, Barbara A Fivush, Alicia M Neu, Susan L Furth.   

Abstract

BACKGROUND: Many patients treated using hemodialysis remain anemic despite exogenous erythropoietin therapy, suggesting that the anemia experienced by these patients is multifactorial in cause. Iron deficiency, infection, inflammation, and malnutrition have been implicated in this process. Additionally, secondary hyperparathyroidism has been associated with anemia in adults, but few data exist about this topic in children. STUDY
DESIGN: Cross-sectional retrospective. SETTING & PARTICIPANTS: Children treated in hemodialysis centers (N = 588) within the Centers for Medicare & Medicaid Services' 2002 Clinical Performance Measures Project. PREDICTOR: Intact parathyroid hormone (iPTH) levels assessed in October, November, and December 2001 and categorized as quintiles. OUTCOMES & MEASUREMENTS: Achievement of serum hemoglobin level > or = 11 g/dL was assessed using Poisson regression adjusting for sex, age, race, dialysis vintage, vascular access type, single-pool Kt/V, serum albumin level, normalized protein catabolic rate, calcium-phosphorus product, and erythropoietin alfa dose.
RESULTS: Using the second quintile (iPTH, 103-224 pg/mL) as the reference quintile, there was no association between iPTH quintile and achievement of the hemoglobin goal: quintile 1 prevalence ratio, 1.0 (95% CI, 0.9-1.2); quintile 3, 0.95 (95% CI, 0.8-1.1); quintile 4, 0.99 (95% CI, 0.8-1.2); and quintile 5, 0.97 (95% CI, 0.8-1.1). Only serum albumin level >/= 3.5 g/dL (bromocresol green assay method) or > or = 3.2 g/dL (bromocresol purple assay method) was significantly associated with meeting the hemoglobin goal: 1.4 (95% CI, 1.2-1.6). LIMITATIONS: The simultaneous collection of iPTH and hemoglobin limits causal inference. Iron stores and iron therapy are potential confounders not accounted for in this study.
CONCLUSIONS: In the largest study of this topic in children, no association was found between iPTH level and achievement of a hemoglobin level > or = 11 g/dL. Serum albumin level was associated strongly with achievement of the hemoglobin goal. Copyright 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20116689      PMCID: PMC2818429          DOI: 10.1053/j.ajkd.2009.09.033

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  27 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

Review 2.  Hyporesponsiveness to recombinant human erythropoietin.

Authors:  T Drüeke
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

3.  Predictors of erythropoietin responsiveness in chronic hemodialysis patients.

Authors:  M Tonelli; P G Blake; N Muirhead
Journal:  ASAIO J       Date:  2001 Jan-Feb       Impact factor: 2.872

4.  Parathyroidectomy in chronic renal failure: short- and long-term results on parathyroid function, blood pressure and anemia.

Authors:  G Coen; S Calabria; G Bellinghieri; F Pecchini; F Conte; M G Chiappini; M Ferrannini; C Lagona; A Mallamace; M Manni; M DiLuca; D Sardella; F Taggi
Journal:  Nephron       Date:  2001-06       Impact factor: 2.847

5.  Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.

Authors:  M M Mitsnefes; S R Daniels; S M Schwartz; R A Meyer; P Khoury; C F Strife
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

Review 6.  The importance of early treatment of the anaemia of chronic kidney disease.

Authors:  G Eknoyan
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

7.  Identification of poor responders to erythropoietin among children undergoing hemodialysis.

Authors:  W Seeherunvong; L Rubio; C L Abitbol; B Montané; J Strauss; R Diaz; G Zilleruelo
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

Review 8.  Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach.

Authors:  Diego Brancaccio; Mario Cozzolino; Maurizio Gallieni
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

Review 9.  Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients.

Authors:  Tilman B Drüeke; Kai-Uwe Eckardt
Journal:  Nephrol Dial Transplant       Date:  2002       Impact factor: 5.992

10.  Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Charles J McAllister; Robert S Lehn; Grace H Lee; Allen R Nissenson; Joel D Kopple
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

View more
  3 in total

Review 1.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

Review 2.  Anemia in children with chronic kidney disease.

Authors:  Meredith A Atkinson; Susan L Furth
Journal:  Nat Rev Nephrol       Date:  2011-09-06       Impact factor: 28.314

3.  Study of Red Cell Fragility in Different Stages of Chronic Kidney Disease in Relation to Parathyroid Hormone.

Authors:  Suchismita Panda; Anuva Mishra; Manoranjan Jena; Sashi Bhusan Rout; Srikrushna Mohapatra
Journal:  J Clin Diagn Res       Date:  2017-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.